The ArQule team has a successful track record of both in-licensing and out-licensing programs and technologies. Having concluded multiple collaborations in the West and in Japan, the ArQule team is an experienced partner in alliance management matters.
With four drug candidates in the clinic and multiple clinical trials ongoing, ArQule has a proven track record for successful clinical development. We actively consider both the partnering of our own proprietary programs and the in-licensing or acquisition of new programs as part of our business strategy.
We welcome the submission of business development proposals related to your products or our own. Please contact us via email. Please note that any business development proposals sent to ArQule will be considered non-confidential. No information that you deem to be confidential should be sent to us without first inquiring about and executing a signed confidentiality agreement.